A goal of ophthalmology researchers is to deliver medication to the back of the eye in a selective and minimally invasive way. An Emory Eye Center scientist and two fellow researchers have investigated opportunities and have recently been awarded a U.S. patent for application of microneedle technology, designed to do just that.
- Groups
-
Parker H. Petit Institute for Bioengineering and Bioscience (IBB)
- Categories
-
Cancer Research, Chemistry and Chemical Engineering, Student and Faculty, Engineering, Life Sciences and Biology, Physics and Physical Sciences
- Keywords
-
Henry F. Edelhauser, Mark Prausnitz, Newly patented microneedle for ocular drug delivery
- Status
-
- Created By: Colly Mitchell
- Workflow Status: Published
- Created On: May 9, 2011 - 7:47am
- Last Updated: Oct 7, 2016 - 10:24pm
